Hostname: page-component-7479d7b7d-k7p5g Total loading time: 0 Render date: 2024-07-11T09:27:12.488Z Has data issue: false hasContentIssue false
  • English
  • Français

CSF GABA in depressed patients and normal controls

Published online by Cambridge University Press:  09 July 2009

Alec Roy ,
Judith Dejong  and
Thomas Ferraro
Alec Roy*
Affiliation:
National Institute of Mental Health, Bethesda, Maryland; Departments of Pharmacology and Neurology, Jefferson Medical College, Philadelphia, USA
Judith Dejong
Affiliation:
National Institute of Mental Health, Bethesda, Maryland; Departments of Pharmacology and Neurology, Jefferson Medical College, Philadelphia, USA
Thomas Ferraro
Affiliation:
National Institute of Mental Health, Bethesda, Maryland; Departments of Pharmacology and Neurology, Jefferson Medical College, Philadelphia, USA
*
1 Address for correspondence: Dr Alec Roy, Hillside Hospital, PO Box 38, Glen Oaks, NY 11004, USA.
Get access Rights & Permissions [Opens in a new window]

Synopsis

The inhibitory neurotransmitter gamma-aminobutyric acid (GABA) has been implicated in the pathophysiology of depression. Therefore, we examined cerebrospinal fluid (CSF) levels of GABA in depressed patients (N = 25) and normal controls (N = 20). There was no significant difference between the groups. However, among the depressed patients the subgroup of unipolar melancholic patients (N = 13) had significantly lower CSF levels of GABA than the rest of the depressed patients (N = 12). There was no significant difference for CSF levels of GABA between depressed patients who were (N = 14) or were not (N = 11) cortisol non-suppressors. It was of interest that among the controls there was a significant negative correlation between CSF levels of GABA and CSF levels of norepinephrine.

Type
Original Articles
Information
Psychological Medicine , Volume 21 , Issue 3 , August 1991 , pp. 613 - 618
Copyright
Copyright © Cambridge University Press 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bartholini, G., Lloyd, K., Scatton, B. & Zivkovic, B. (1989). GABA theory of depression and antidepressant drug action. In New Directions in Affective Disorders (ed. Lerer, B. and Gershon, S.), pp. 651–654. Springer-Verlag: New York.CrossRefGoogle Scholar
Berrettini, W. & Post, R. (1984). GABA in affective illness. In Neurobiology of Mood Disorders (ed. Post, R. and Ballenger, J.), pp. 673–685. Williams and Wilkins: New York.Google Scholar
Berrettini, W., Nurnberger, J. Jr., Hare, T., Simmons-Alling, S., Gershon, E. & Post, R. (1983). Reduced plasma and CSF GABA in affective illness. Effect of lithium carbonate. Biologica Psychiatry 18, 185–194.Google ScholarPubMed
Berrettini, W., Nurnberger, J., Hare, T. & Gershon, S. (1985). CSF GABA in bipolar affective illness. In Proceedings of the World Congress of Biological Psychiatry, (ed. Shagass, C., Josiassen, R., Bridger, W., Weiss, K., Stoff, D. and Simpson, G.), pp. 926–928. Elsevier; Amsterdam.Google Scholar
Bohlen, P., Huot, S. & Palfreyman, M. (1979). The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Research 167, 297–305.CrossRefGoogle ScholarPubMed
Carroll, B., Feinberg, M., Greden, J., Tarika, J., Albala, A., Haskett, R., James, N., Kronfol, Z., Lohr, N., Steiner, M., DeVigne, J. & Young, E. (1981). A specific laboratory test for the diagnoisis of melancholia: standardization, validation, and clinical utility. Archives of General Psychiatry 38, 15–22.CrossRefGoogle Scholar
Dennis, T., Curet, O., Nishikawa, T. & Scatton, B. (1985). Further evidence for, and nature of the facilitatory GABAergic influence on central noradrenergic transmission. Naunyn-Schmiedeberg's Archives of Pharmacology 331, 225–234.CrossRefGoogle ScholarPubMed
Endicott, J. & Spitzer, R. (1979). A diagnostic interview: the schedule for affective disorder and schizophrenia. Archives of General Psychiatry 35, 837–844.CrossRefGoogle Scholar
Ferraro, T. & Hare, T. (1984 a). Triple column ion-exchange physiological amino-acid analysis with fluorometric detection: baseline characterization of human CSF. Analytical Biochemistry 143, 82–94.CrossRefGoogle Scholar
Ferraro, T. & Hare, T. (1984 b). Ion-exchange/fluorometric assay with enhanced resolution for GABA in CSF. Society of Neurosciences Abstract 10, 892.Google Scholar
Fonnum, F. (1987). Biochemistry, anatomy and pharmacology of GABA neurons. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H.), pp. 173–182. Raven Press: New York.Google Scholar
Fuxe, K., Agnati, L., Bolme, P., Hokfelt, T., Lidbrink, P., Ljungdahl, A., Peres dela Mora, M. & Orgen, S. (1975). The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. In Mechanisms of Actions of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 45–52. Raven Press: New York.Google ScholarPubMed
Gerner, R. & Hare, T. (1981). CSF GABA in normals, depression, schizophrenia, mania and anorexia nervosa. American Journal of Psychiatry 138, 1098–1101.Google ScholarPubMed
Gerner, R., Fairbanks, L., Anderson, G., Young, J., Scheinin, M., Linnoila, M., Hare, T., Shaywitz, B. & Cohen, D. (1984). CSF neurochemistry in depressed, manic and schizophrenic patients compared with that of normal controls. American Journal of Psychiatry 141, 1533–1540.Google ScholarPubMed
Gold, B., Bower, M. Jr., Roth, R. & Sweeney, D. W. (1980). GABA levels in CSF of patients with psychiatric disorders. American Journal of Psychiatry 137, 362–364.Google ScholarPubMed
Hamilton, M. (1960). A rating scale for depression. Journal of Neurosurgery and Psychiatry 139, 297–305.Google Scholar
Hare, T. (1981). Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurement of GABA and GAD activity of cerebrospinal fluid. Molecular and Cellular Biochemistry 39, 297–304.CrossRefGoogle ScholarPubMed
Hare, T. & Manyam, N. (1980). Rapid and sensitive ion-exchange/fluorometric measurement of GABA in physiological fluids. Analytical Biochemistry 101, 349–355.CrossRefGoogle ScholarPubMed
Hare, T., Wood, J., Manyam, N., Gerner, R., Ballenger, J. & Post, R. (1982). Central nervous system γ-aminobutyric acid activity in man related to age and sex as reflected in cerebrospinal fluid. Archives of Neurology 39, 247–249.CrossRefGoogle Scholar
Kasa, K., Otsuki, S., Yamamoto, M., Sato, M., Kuroda, H. & Ogawa, N. (1982). CSF GABA and HVA in depressive disorders. Biological Psychiatry 17, 877–883.Google ScholarPubMed
Lloyd, K. & Morselli, P. (1987). Psychopharmacology of GABAergic drugs. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H.); pp. 183–195. Raven Press: New York.Google Scholar
Lloyd, K. G., Morselli, P. L., Depoortere, H., Fournier, V., Zivkovic, B., Scatton, B., Broekkamp, C., Worms, P. & Bartholini, G. (1983). The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacology, Biochemistry and Behavior 18, 957–966.CrossRefGoogle ScholarPubMed
Lloyd, K. G., Thuret, F. & Pilc, A. (1986). GABA and mechanism of action of antidepressant drugs. In GABA and Mood Disorders: Experimental and Clinical Research. (ed. Bartholini, G., Lloyd, K. G. and Morselli, P. L.), pp. 33–42. Raven Press: New York.Google Scholar
Petty, F. & Sherman, D. (1981). GABAergic modulation of learned helplessness. Pharmacology, Biochemistry and Behavior 15, 567–570.CrossRefGoogle ScholarPubMed
Post, R., Ballenger, J., Hare, T., Goodwin, F., Lake, C., Jimerson, D. & Bunney, W. Jr. (1980). CSF GABA in normals and patients with affective disorder. Brain Research Bulletin 5, 755–759.CrossRefGoogle Scholar
Roberts, E., Chase, T. & Tower, D. (eds.) (1976). GABA in Nervous System Function. Raven Press: New York.Google Scholar
Roy, A., Pickar, D. & Paul, S. (1984). Biologic tests in depression. Psychosomatics 25, 443–451.CrossRefGoogle ScholarPubMed
Roy, A., Pickar, D., Linnoila, M., Doran, A., Ninan, P. & Paul, S. (1985 a). Cerebrospinal fluid monoamine and monoamine metabolites in melancholia. Psychiatry Research 15, 281–292.CrossRefGoogle ScholarPubMed
Roy, A., Pickar, D., Linnoila, M. & Potter, W. (1985 b). Plasma norepinephrine in affective disorders: relationship to melancholia. Archives of General Psychiatry 42, 1181–1185.CrossRefGoogle ScholarPubMed
Roy, A., Pickar, D., DeJong, J., Karoum, F. & Linnoila, M. (1988). Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Archives of General Psychiatry 45, 849–857.CrossRefGoogle ScholarPubMed
Roy, A., DeJong, J., Ferraro, T., Adinoff, B., Ravitz, B. & Linnoila, M. (1990). CSF γ-aminobutyric acid in alcoholics and control subjects. American Journal of Psychiatry 147, 1294–1296.Google ScholarPubMed
Scheinin, M., Chang, W., Kirk, K. & Linnoila, M. (1983). Simultaneous determination of 3-methoxy-4-hydroxphenylglycol, 5-hydroxy-indoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Analytical Biochemistry 131, 246–253.CrossRefGoogle Scholar
Sherman, D. & Petty, F. (1980). Neurochemical basis of the action of antidepressants on learned helplessness. Behavior, Neurology and Biology 30, 119–134.CrossRefGoogle ScholarPubMed